Sapinmusaponin O



Compound IDCDAMM01097
Common nameSapinmusaponin O
IUPAC name2-[4,5-dihydroxy-2-[[7-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Molecular formulaC42H72O12

Experimental data

Retention time0.35
Adduct[M+Na]+
Actual mz791.499
Theoretical mz791.491
Error9.58
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.4255

Identifiers and class information

Inchi keyWTZRMMRIVFYQRE-UHFFFAOYNA-N
SmilesOCC1OC(OC2CCC3(C)C4CCC5C(CCC5(C)C4(C)C(O)CC3C2(C)C)C(O)(C)CCC=C(C)C)C(OC6OC(C)C(O)C(O)C6O)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)769.024
Computed dipole moment(dipole)7.681
Total solvent accessible surface area (SASA)1075.26
Hydrophobic component of SASA (FOSA)828.103
Hydrophilic component of SASA (FISA)234.501
Pie component of the SASA (PISA)12.657
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2258.72
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)19.45
Free energy of solvation of dipole (dip^2/V)0.0261229
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0511624
Globularity descriptor (glob)0.774272
Predicted polarizability in cubic angstroms (QPpolrz)73.445
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.406
Predicted octanol/gas partition coefficient (QPlogPoct)47.343
Predicted water/gas partition coefficient (QPlogPw)31.113
Predicted octanol/water partition coefficient (QPlogPo/w)2.821
Predicted aqueous solubility (QPlogS)-5.543
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.479
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.245
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)59.174
Predicted brain/blood partition coefficient (QPlogBB)-3.069
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)23.29
Predicted skin permeability, log Kp (QPlogKp)-4.165
PM3 calculated ionization potential (IP(ev))9.694
PM3 calculated electron affinity (EA(eV))-0.84
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.009
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)36.306
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)183.504
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A

Copyright © 2025